In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Researchers at the Perelman School of Medicine identified over 1,000 genes that could serve as potential treatment targets for kidney disease in a newly published study. The study marks the most ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...